Collaborative approaches are becoming a key driver in drug discovery and development. They come in many types and forms ranging from project-based collaborations and strategic alliances to large international consortia. The volume discusses various types of such collaboration including the specific uses, advantages, and challenges. Based on the nature of public-private partnerships, we present views and experiences from academia, industry, and public stakeholders.
表中的内容
Novel and proven models of Public Private and Public Private Partnerships in Healthcare An Update.- Project based Public private collaborations.- Collaborative Innovations in Childhood Cancer Therapies.- Reaching outer space and enabling the m RNA revolution a critical role of partnerships for successful drug and vaccine development.- The Alliance between the German Cancer Research Center and Bayer a retrospective of an innovative collaboration model.- Life Science Incubation at Lab Central Bio Labs with Partners Extending from the US to Europe.- Innovation at the Interface between Academia and Industry The Bio Med X Model.- From innovator result driven to multi actor impact oriented Public Private Partnerships Integrating the patient perspective.- The Legal Framework for PPP in Drug R&D.
来自同一作者的更多电子书 / 编辑
1,362 此类电子书
